Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

Robert C. Gosselin, William E. Dager, Jeffrey H. King, Kim Janatpour, Kathleen Mahackian, Edward C. Larkin, John T Owings

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. The DTIs frequently are used to provide initial anticoagulation, with long-term therapy requiring eventual transition to coumarins. Unfortunately, DTIs not only prolong the activated partial thromboplastin time but also can affect international normalized ratio (INR) values. We approximated the DTI effect on INRs by each drug to pooled plasma at concentrations between 0.1 and 1.2 μg/mL. We then concurrently tested these samples using 14 prothrombin time (PT) reagents. By using repeated measures analysis of variance, we found significant differences (P < .05) between the median INRs for lepirudin and argatroban for all PT reagents, between lepirudin and bivalirudin for all reagents except PT-Fibrinogen HS Plus (P = .07), and between bivalirudin and argatroban for all reagents except Thromborel S (P = .05). The DTI effect on INRs was dependent on drug, drug concentration, and reagent. Argatroban had the most effect on INRs, while lepirudin had the least effect. Reagents with a lower international sensitivity index were less affected by DTI; ThromboMax HS was the least sensitive PT reagent to any DTI.

Original languageEnglish (US)
Pages (from-to)593-599
Number of pages7
JournalAmerican Journal of Clinical Pathology
Volume121
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

International Normalized Ratio
Antithrombins
Prothrombin Time
Pharmaceutical Preparations
Coumarins
Partial Thromboplastin Time
bivalirudin
lepirudin
argatroban
Anticoagulants
Fibrinogen
Analysis of Variance

Keywords

  • Argatroban
  • Bivalirudin
  • Direct thrombin inhibitors
  • INR
  • International normalized ratio
  • Lepirudin
  • Prothrombin time

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values. / Gosselin, Robert C.; Dager, William E.; King, Jeffrey H.; Janatpour, Kim; Mahackian, Kathleen; Larkin, Edward C.; Owings, John T.

In: American Journal of Clinical Pathology, Vol. 121, No. 4, 04.2004, p. 593-599.

Research output: Contribution to journalArticle

Gosselin, Robert C. ; Dager, William E. ; King, Jeffrey H. ; Janatpour, Kim ; Mahackian, Kathleen ; Larkin, Edward C. ; Owings, John T. / Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values. In: American Journal of Clinical Pathology. 2004 ; Vol. 121, No. 4. pp. 593-599.
@article{df5924b784c94e16a646401e837fe628,
title = "Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values",
abstract = "Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. The DTIs frequently are used to provide initial anticoagulation, with long-term therapy requiring eventual transition to coumarins. Unfortunately, DTIs not only prolong the activated partial thromboplastin time but also can affect international normalized ratio (INR) values. We approximated the DTI effect on INRs by each drug to pooled plasma at concentrations between 0.1 and 1.2 μg/mL. We then concurrently tested these samples using 14 prothrombin time (PT) reagents. By using repeated measures analysis of variance, we found significant differences (P < .05) between the median INRs for lepirudin and argatroban for all PT reagents, between lepirudin and bivalirudin for all reagents except PT-Fibrinogen HS Plus (P = .07), and between bivalirudin and argatroban for all reagents except Thromborel S (P = .05). The DTI effect on INRs was dependent on drug, drug concentration, and reagent. Argatroban had the most effect on INRs, while lepirudin had the least effect. Reagents with a lower international sensitivity index were less affected by DTI; ThromboMax HS was the least sensitive PT reagent to any DTI.",
keywords = "Argatroban, Bivalirudin, Direct thrombin inhibitors, INR, International normalized ratio, Lepirudin, Prothrombin time",
author = "Gosselin, {Robert C.} and Dager, {William E.} and King, {Jeffrey H.} and Kim Janatpour and Kathleen Mahackian and Larkin, {Edward C.} and Owings, {John T}",
year = "2004",
month = "4",
doi = "10.1309/D79K-4YG7-8NTN-YY38",
language = "English (US)",
volume = "121",
pages = "593--599",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

AU - Gosselin, Robert C.

AU - Dager, William E.

AU - King, Jeffrey H.

AU - Janatpour, Kim

AU - Mahackian, Kathleen

AU - Larkin, Edward C.

AU - Owings, John T

PY - 2004/4

Y1 - 2004/4

N2 - Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. The DTIs frequently are used to provide initial anticoagulation, with long-term therapy requiring eventual transition to coumarins. Unfortunately, DTIs not only prolong the activated partial thromboplastin time but also can affect international normalized ratio (INR) values. We approximated the DTI effect on INRs by each drug to pooled plasma at concentrations between 0.1 and 1.2 μg/mL. We then concurrently tested these samples using 14 prothrombin time (PT) reagents. By using repeated measures analysis of variance, we found significant differences (P < .05) between the median INRs for lepirudin and argatroban for all PT reagents, between lepirudin and bivalirudin for all reagents except PT-Fibrinogen HS Plus (P = .07), and between bivalirudin and argatroban for all reagents except Thromborel S (P = .05). The DTI effect on INRs was dependent on drug, drug concentration, and reagent. Argatroban had the most effect on INRs, while lepirudin had the least effect. Reagents with a lower international sensitivity index were less affected by DTI; ThromboMax HS was the least sensitive PT reagent to any DTI.

AB - Direct thrombin inhibitors (DTIs) represent a new class of promising anticoagulation agents. The DTIs frequently are used to provide initial anticoagulation, with long-term therapy requiring eventual transition to coumarins. Unfortunately, DTIs not only prolong the activated partial thromboplastin time but also can affect international normalized ratio (INR) values. We approximated the DTI effect on INRs by each drug to pooled plasma at concentrations between 0.1 and 1.2 μg/mL. We then concurrently tested these samples using 14 prothrombin time (PT) reagents. By using repeated measures analysis of variance, we found significant differences (P < .05) between the median INRs for lepirudin and argatroban for all PT reagents, between lepirudin and bivalirudin for all reagents except PT-Fibrinogen HS Plus (P = .07), and between bivalirudin and argatroban for all reagents except Thromborel S (P = .05). The DTI effect on INRs was dependent on drug, drug concentration, and reagent. Argatroban had the most effect on INRs, while lepirudin had the least effect. Reagents with a lower international sensitivity index were less affected by DTI; ThromboMax HS was the least sensitive PT reagent to any DTI.

KW - Argatroban

KW - Bivalirudin

KW - Direct thrombin inhibitors

KW - INR

KW - International normalized ratio

KW - Lepirudin

KW - Prothrombin time

UR - http://www.scopus.com/inward/record.url?scp=1642317572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642317572&partnerID=8YFLogxK

U2 - 10.1309/D79K-4YG7-8NTN-YY38

DO - 10.1309/D79K-4YG7-8NTN-YY38

M3 - Article

VL - 121

SP - 593

EP - 599

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -